[HTML] sciencedirect.com

[HTML][HTML] Peptide-based supramolecular vaccine systems

CL O'Neill, PC Shrimali, ZE Clapacs, MA Files… - Acta biomaterialia, 2021 - Elsevier
Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …
被引用次数：45 相关文章

Peptide-based supramolecular vaccine systems

CL O'Neill, PC Shrimali, ZE Clapacs… - Acta …, 2021 - pubmed.ncbi.nlm.nih.gov
Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …
[HTML] nih.gov

[HTML][HTML] Peptide-based supramolecular vaccine systems

CL O'Neill, PC Shrimali, ZE Clapacs, MA Files… - Acta …, 2021 - ncbi.nlm.nih.gov
Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …

Peptide-based supramolecular vaccine systems.

CL O'Neill, PC Shrimali, ZP Clapacs, MA Files… - Acta …, 2021 - europepmc.org
Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …

Peptide-based supramolecular vaccine systems

CL O'Neill, PC Shrimali, ZP Clapacs, MA Files… - Acta …, 2021 - profiles.wustl.edu
Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …

Peptide-Based Supramolecular Vaccine Systems

CL O'Neill, PC Shrimali, ZP Clapacs, MA Files… - Available at SSRN … - papers.ssrn.com
Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …